Literature DB >> 12951023

Analysis of the complete genome of the tick-borne flavivirus Omsk hemorrhagic fever virus.

Di Lin1, Li Li, Daryl Dick, Robert E Shope, Heinz Feldmann, Alan D T Barrett, Michael R Holbrook.   

Abstract

Omsk hemorrhagic fever virus (OHF) is a tick-borne flavivirus endemic to Western Siberia. This virus is the only known tick-borne flavivirus to cause hemorrhagic disease in humans in the absence of encephalitis. OHF virus circulates within a small, defined niche in which other tick-borne complex flaviviruses are also present. The objectives of this study were to genetically classify OHF virus based on its complete genome and to identify genetic determinants that might be involved in tissue tropism and viral replication leading to the disease state caused by this virus. The OHF virus genome was sequenced and phylogenetic analysis demonstrated that OHF virus falls within the tick-borne encephalitis serocomplex of flaviviruses, yet is distinct from other members of the complex, including those closely associated geographically. OHF is also distinct from Alkhurma (ALK) and Kyasanur forest disease (KFD) viruses, both of which cause disease that includes hemorrhagic and encephalitic manifestations. Several amino acid residues were found to be distinct among OHF, KFD, and ALK viruses; these residues include E-76, which is closely associated with the viral envelope protein fusion peptide. In addition, variation between the viral 5'-untranslated region of OHF and other tick-borne flaviviruses suggests potential variability in viral replication. These data demonstrate that OHF is a unique virus among the tick-borne flaviviruses and also provide insight to viral biodiversity and tropism.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12951023     DOI: 10.1016/s0042-6822(03)00246-0

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  7 in total

1.  Use of recombinant E protein domain III-based enzyme-linked immunosorbent assays for differentiation of tick-borne encephalitis serocomplex flaviviruses from mosquito-borne flaviviruses.

Authors:  Michael R Holbrook; Robert E Shope; Alan D T Barrett
Journal:  J Clin Microbiol       Date:  2004-09       Impact factor: 5.948

Review 2.  Kyasanur forest disease.

Authors:  Michael R Holbrook
Journal:  Antiviral Res       Date:  2012-10-27       Impact factor: 5.970

3.  Low diversity of Alkhurma hemorrhagic fever virus, Saudi Arabia, 1994-1999.

Authors:  Rémi N Charrel; Ali Mohamed Zaki; Mazen Fakeeh; Amany Ibrahim Yousef; Reine de Chesse; Houssam Attoui; Xavier de Lamballerie
Journal:  Emerg Infect Dis       Date:  2005-05       Impact factor: 6.883

Review 4.  Exploiting the Legacy of the Arbovirus Hunters.

Authors:  Nikos Vasilakis; Robert B Tesh; Vsevolod L Popov; Steve G Widen; Thomas G Wood; Naomi L Forrester; Jean Paul Gonzalez; Jean Francois Saluzzo; Sergey Alkhovsky; Sai Kit Lam; John S Mackenzie; Peter J Walker
Journal:  Viruses       Date:  2019-05-23       Impact factor: 5.048

5.  First Indications of Omsk Haemorrhagic Fever Virus beyond Russia.

Authors:  Edith Wagner; Anna Shin; Nur Tukhanova; Nurkeldi Turebekov; Talgat Nurmakhanov; Vitaliy Sutyagin; Almas Berdibekov; Nurbek Maikanov; Ilmars Lezdinsh; Zhanna Shapiyeva; Alexander Shevtsov; Klaus Freimüller; Lukas Peintner; Christina Ehrhardt; Sandra Essbauer
Journal:  Viruses       Date:  2022-04-04       Impact factor: 5.818

6.  Isolation of kyasanur forest disease virus from febrile patient, yunnan, china.

Authors:  Jinglin Wang; Hailin Zhang; Shihong Fu; Huanyu Wang; Daxin Ni; Roger Nasci; Qing Tang; Guodong Liang
Journal:  Emerg Infect Dis       Date:  2009-02       Impact factor: 6.883

Review 7.  Epidemiology, Pathogenesis, and Control of a Tick-Borne Disease- Kyasanur Forest Disease: Current Status and Future Directions.

Authors:  Syed Z Shah; Basit Jabbar; Nadeem Ahmed; Anum Rehman; Hira Nasir; Sarooj Nadeem; Iqra Jabbar; Zia Ur Rahman; Shafiq Azam
Journal:  Front Cell Infect Microbiol       Date:  2018-05-09       Impact factor: 5.293

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.